News from pronai therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages


27 Sep, 2016, 12:15 BST ProNAi Licenses Oncology Drug Targeting DNA Damage Response Checkpoint Kinase 1 (Chk1) From CRT Pioneer Fund, UK

- PNT737 Currently in Phase 1 Clinical Trials at the Royal Marsden, London, UK - Potential to Exploit Cancer-Driving Genetic Mutations to Achieve...